3SBio Past Performance
How has 3SBio performed over the past 5 years?
Past Performance Score
5/6Past Performance Score 5/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
9.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1530 has high quality earnings.
Growing Profit Margin: 1530's current net profit margins (26.8%) are higher than last year (17.2%).
Past Earnings Growth Analysis
Earnings Trend: 1530's earnings have grown by 9.7% per year over the past 5 years.
Accelerating Growth: 1530's earnings growth over the past year (65.4%) exceeds its 5-year average (9.7% per year).
Earnings vs Industry: 1530 earnings growth over the past year (65.4%) exceeded the Biotechs industry -7.7%.
Return on Equity
High ROE: 1530's Return on Equity (11.6%) is considered low.